These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 2429117)

  • 21. Antianginal effects of atenolol and pindolol in patients with stable effort angina pectoris.
    Antalóczy Z; Kekes E
    Zhongguo Yao Li Xue Bao; 1989 May; 10(3):222-6. PubMed ID: 2609991
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clonidine effect in chronic angina pectoris. Double-blind, crossover trial on 60 patients.
    Ceremuzyński L; Zaleska T; Lada W; Zalewski A
    Eur J Cardiol; 1979 Dec; 10(6):415-27. PubMed ID: 116856
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antianginal efficacy and safety of ivabradine compared with amlodipine in patients with stable effort angina pectoris: a 3-month randomised, double-blind, multicentre, noninferiority trial.
    Ruzyllo W; Tendera M; Ford I; Fox KM
    Drugs; 2007; 67(3):393-405. PubMed ID: 17335297
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of partial agonist activity in beta blockers in severe angina pectoris: a double blind comparison of pindolol and atenolol.
    Quyyumi AA; Wright C; Mockus L; Fox KM
    Br Med J (Clin Res Ed); 1984 Oct; 289(6450):951-3. PubMed ID: 6148991
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of sublingual pentrinitrol on exercise tolerance in angina pectoris.
    Giles TD; Holder JT
    J Clin Pharmacol; 1978; 18(8-9):407-13. PubMed ID: 357455
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect on exercise tolerance and pharmacokinetics of conventional and sustained release preparations of propranolol in patients with angina pectoris--a double-blind cross-over study.
    Kambara H; Kinoshita M; Hirota Y; Kadota K; Sawamura M; Saito T; Kawai C
    Jpn Circ J; 1984 Oct; 48(10):1066-73. PubMed ID: 6387210
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Verapamil therapy for stable exertional angina pectoris.
    Weiner DA; Klein MD
    Am J Cardiol; 1982 Nov; 50(5):1153-7. PubMed ID: 6814225
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Metoprolol, nifedipine, and the combination in stable effort angina pectoris.
    Uusitalo A; Arstila M; Bae EA; Härkönen R; Keyriläinen O; Rytkönen U; Schjelderup-Mathiesen PM; Wendelin H
    Am J Cardiol; 1986 Apr; 57(10):733-7. PubMed ID: 3083664
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antianginal and anti-ischemic efficacy of nicorandil compared with nifedipine in patients with angina pectoris and coronary heart disease: a double-blind, randomized, multicenter study.
    Ulvenstam G; Diderholm E; Frithz G; Gudbrandsson T; Hedbäck B; Höglund C; Moelstad P; Perk J; Sverrisson JT
    J Cardiovasc Pharmacol; 1992; 20 Suppl 3():S67-73. PubMed ID: 1282179
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of naloxone on exercise-induced angina pectoris: a randomized double blind crossover trial.
    van Rijn T; Rabkin SW
    Life Sci; 1986 Feb; 38(7):609-15. PubMed ID: 3511346
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Exercise tolerance in angina is improved by mivazerol--an alpha 2-adrenoceptor agonist.
    Wright RA; Decroly P; Kharkevitch T; Oliver MF
    Cardiovasc Drugs Ther; 1993 Dec; 7(6):929-34. PubMed ID: 7912103
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antihypertensive effects of urapidil and clonidine: a double-blind cross-over study.
    Kanniainen E; Heikkilä O; Jääskeläinen T; Lilja M; Jounela AJ
    Eur J Clin Pharmacol; 1985; 28(1):35-9. PubMed ID: 3886400
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Calcium channel blockade as primary therapy for stable angina pectoris. A double-blind placebo-controlled comparison of verapamil and propranolol.
    Subramanian VB; Bowles MJ; Davies AB; Raftery EB
    Am J Cardiol; 1982 Nov; 50(5):1158-63. PubMed ID: 6127945
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Double-blind, dose-response, placebo-controlled multicenter study of nisoldipine. A new second-generation calcium channel blocker in angina pectoris.
    Thadani U; Zellner SR; Glasser S; Bittar N; Montoro R; Miller AB; Chaitman B; Schulman P; Stahl A; DiBianco R
    Circulation; 1991 Dec; 84(6):2398-408. PubMed ID: 1959195
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Comparative evaluation using an ergometric test of the efficacy of the 3 major calcium antagonists on exertion stable angina].
    Papa M; Acanfora D; Artiaco D; Santangelo L; Covelluzzi F; De Rosa ML; Cicatiello M; De Caprio L; Rengo F
    G Ital Cardiol; 1987 Apr; 17(4):344-50. PubMed ID: 3653591
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparative antianginal effects of bepridil and propranolol in angina pectoris.
    Parker JO; Farrell B
    Am J Cardiol; 1986 Sep; 58(6):449-52. PubMed ID: 3529909
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antianginal and haemodynamic effects of alpha 1-adrenoceptor blockade.
    Sheridan DJ; Thomas P; Culling W; Collins P
    J Cardiovasc Pharmacol; 1986; 8 Suppl 2():S144-50. PubMed ID: 2423788
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of combined alpha and beta adrenoceptor blockade in patients with angina pectoris. A double blind study comparing labetalol with placebo.
    Quyyumi AA; Wright C; Mockus L; Shackell M; Sutton GC; Fox KM
    Br Heart J; 1985 Jan; 53(1):47-52. PubMed ID: 3881105
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diltiazem, nifedipine, and their combination in patients with stable angina pectoris: effects on angina, exercise tolerance, and the ambulatory electrocardiographic ST segment.
    Frishman W; Charlap S; Kimmel B; Teicher M; Cinnamon J; Allen L; Strom J
    Circulation; 1988 Apr; 77(4):774-86. PubMed ID: 3280158
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of a new metabolic modulator, ranolazine, on exercise tolerance in angina pectoris patients treated with beta-blocker or diltiazem.
    Cocco G; Rousseau MF; Bouvy T; Cheron P; Williams G; Detry JM; Pouleur H
    J Cardiovasc Pharmacol; 1992 Jul; 20(1):131-8. PubMed ID: 1383622
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.